Skip to content

Dr. Maes Lotte

Active
Private limited companyfounded 2018active for 8 yearsDennendreef 7, 2350 Vosselaar, BelgiumKBO/BCE: BE 0699.663.968
Summary

Dr. Maes Lotte has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,600 and a net result of €130,180. Equity has been shrinking by about 41% per year since 2018. If that trend continues, it turns negative around financial year 2026. Its solvency ranks better than 5% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 04-07-2018 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.278.274.533 2350 Vosselaar, since 05-07-2018
Financial year end
31 December
Peppol
Reachable since 18-11-2025

Board and ownership

Board

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€188,258
▼ 0.3%
Turnover
≈ €340,000
estimated
Profit
€130,180
▲ 1.2%
Equity
€1,600
=
Total assets
€202,396
▼ 13.5%
Staff
≈ 0 FTE
estimated
Score breakdownraises riskEquity €1,600 (0.8% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €202,396Liquidity: current ratio 1.02, cash €108,110Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 38% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 26=
equity 0.8% of total assets
Liquidity 56-1
short-term debt 80.4% · cash 53.4%
Profitability 100=
return on assets 64.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026highest value 04-2026: < 0.1%▼ -0.1 percentage points vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 5% of them on solvency, 32% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €202,396
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €1,600 (0.8% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.02, cash €108,110
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20706 sector peers (2025).
NBB · sector comparison
Position among 20706 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-03-2026, 129 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
129 days early
2024
72 days early
2023
55 days early
2022
118 days early
2021
82 days early
2020
2 days early
2019
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 70 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 May (4 of the last 5 accounts filed within 36 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 95% of companies in human healthsector median 63.0% · 20,706 companies 0.8% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €130,180 8 years View

Recent changes

  1. · Gazette deed Change of role: Maes,Lotte Paul Irene Cecilia, from manager to enige niet statutaire bestuurder
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as Dr. Maes Lotte: general medical practice (NACE 86210). They are comparable in size and age: total assets between €187,000 and €223,000, founded between 2017 and 2019.

CompanyTotal assetsGross margin
Dr. Maes Lotte Vosselaar€202,396€188,258
Dokter Marie Smets Vosselaar€187,391€196,827
MEDISCH CENTRUM OOST Malle€222,620€184,141
Dokter I de Wergifosse Hasselt€216,370€196,654
Dr. avennet Roeselare€215,452€200,996
Dr. Katrien Devos Ieper€217,014€174,438
Dr. Jan Bontinck - Vasculair chirurg Gent€222,064€175,901
Full comparison

Key facts about Dr. Maes Lotte

What is the company number of Dr. Maes Lotte?
The company number of Dr. Maes Lotte is 0699.663.968. The VAT number is the same number with BE in front: BE 0699.663.968.
Where is Dr. Maes Lotte based?
The registered office is at Dennendreef 7, 2350 Vosselaar.Company details
What does Dr. Maes Lotte do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Maes Lotte?
The legal form of Dr. Maes Lotte is Private limited company (BV).
When was Dr. Maes Lotte founded?
Dr. Maes Lotte was founded on 04-07-2018.
Is Dr. Maes Lotte still active?
Yes, Dr. Maes Lotte is an active enterprise in the KBO register.
What is the turnover of Dr. Maes Lotte?
The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €188,258 and 30 comparable companies (NACE 86210). It probably lies between €270,000 and €420,000.Financials
Is Dr. Maes Lotte profitable?
In financial year 2025, Dr. Maes Lotte made a profit of €130,180.
Where can I find the annual accounts of Dr. Maes Lotte?
Dr. Maes Lotte filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Maes Lotte due?
Dr. Maes Lotte must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.